Clinical Trial Update: Concurrent Chemo-radiotherapy With Intensity-Modulated Radiation Therapy (IMRT) for Limited Disease Small Cell Lung Cancer (LD-SCLC) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating concurrent chemotherapy with intensity-modulated radiotherapy for limited-stage small cell lung cancer. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: Maastricht Radiation Oncology | Conditions: Stage I-III Small Cell Lung Cancer | Phase 2 | Status: COMPLETED